Carregant...
Recent advances in prognostication and treatment of polycythemia vera
Polycythemia vera (PV) is a BCR-ABL–negative myeloproliferative neoplasm marked by acquisition of an activating mutation of JAK2, which leads to not only erythrocytosis but also frequently to leukocytosis and thrombocytosis, and is associated with a high symptom burden and increased thrombotic risk....
Guardat en:
| Publicat a: | Fac Rev |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Faculty Opinions Ltd
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8009192/ https://ncbi.nlm.nih.gov/pubmed/33817698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12703/r/10-29 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|